![Targeting FGFR pathway in human hepatocellular carcinoma (HCC) expressing pFGFR and pMET for anti-tumor activity.]()
Targeting FGFR pathway in human hepatocellular carcinoma (HCC) expressing pFGFR and pMET for anti-tumor activity.Jo, J.-C.; Choi, E.-K.; Shin, J.-S.; Moon, J.-H.; Hong, S.-W.; Lee, H.-R.; Kim, S.-M.; Jung, S.-A.; Lee, D.-H.; Jung, S. H.; Lee, S.-H.; Kim, J. E.; Kim, K.-p.; Hong, Y. S.; Suh, Y.-A.; Jang, S. J.; Choi, E. K.; Lee, J. S.; Jin, D. H.; Kim, T. W. · Molecular Cancer Therapeutics · 2015